These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26518061)

  • 1. Hemodynamic safety and efficacy of ferumoxytol as an intravenous contrast agents in pediatric patients and young adults.
    Ning P; Zucker EJ; Wong P; Vasanawala SS
    Magn Reson Imaging; 2016 Feb; 34(2):152-8. PubMed ID: 26518061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children.
    Ruangwattanapaisarn N; Hsiao A; Vasanawala SS
    Pediatr Radiol; 2015 Jun; 45(6):831-9. PubMed ID: 25427433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferumoxytol use as an intravenous contrast agent for magnetic resonance angiography.
    Stabi KL; Bendz LM
    Ann Pharmacother; 2011 Dec; 45(12):1571-5. PubMed ID: 22045905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive motion-compensated highly accelerated 4D flow MRI with ferumoxytol enhancement for pediatric congenital heart disease.
    Cheng JY; Hanneman K; Zhang T; Alley MT; Lai P; Tamir JI; Uecker M; Pauly JM; Lustig M; Vasanawala SS
    J Magn Reson Imaging; 2016 Jun; 43(6):1355-68. PubMed ID: 26646061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of ferumoxytol-enhanced neonatal and young infant cardiac MRI without general anesthesia.
    Lai LM; Cheng JY; Alley MT; Zhang T; Lustig M; Vasanawala SS
    J Magn Reson Imaging; 2017 May; 45(5):1407-1418. PubMed ID: 27678106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults.
    Muehe AM; Feng D; von Eyben R; Luna-Fineman S; Link MP; Muthig T; Huddleston AE; Neuwelt EA; Daldrup-Link HE
    Invest Radiol; 2016 Apr; 51(4):221-227. PubMed ID: 26656202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of ferumoxytol in children undergoing cardiac MRI under general anaesthesia.
    Wise-Faberowski L; Velasquez N; Chan F; Vasanawala S; McElhinney DB; Ramamoorthy C
    Cardiol Young; 2018 Jul; 28(7):916-921. PubMed ID: 29848399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brand ferumoxytol vs. generic ferumoxytol comparison across two dosing regimens: a cardiac MRI image quality study.
    Dasi A; Kring DN; Selvaraj B; Morgan P; Gerity C; Morgan EE; Krishnamurthy R; Krishnamurthy R
    Pediatr Radiol; 2023 Dec; 53(13):2622-2632. PubMed ID: 37837456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol.
    Luhar A; Khan S; Finn JP; Ghahremani S; Griggs R; Zaritsky J; Salusky I; Hall TR
    Pediatr Radiol; 2016 Aug; 46(9):1332-40. PubMed ID: 27059620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.
    Nguyen KL; Park EA; Yoshida T; Hu P; Finn JP
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):106. PubMed ID: 29284494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
    Neuwelt EA; Várallyay CG; Manninger S; Solymosi D; Haluska M; Hunt MA; Nesbit G; Stevens A; Jerosch-Herold M; Jacobs PM; Hoffman JM
    Neurosurgery; 2007 Apr; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI.
    Nguyen KL; Yoshida T; Kathuria-Prakash N; Zaki IH; Varallyay CG; Semple SI; Saouaf R; Rigsby CK; Stoumpos S; Whitehead KK; Griffin LM; Saloner D; Hope MD; Prince MR; Fogel MA; Schiebler ML; Roditi GH; Radjenovic A; Newby DE; Neuwelt EA; Bashir MR; Hu P; Finn JP
    Radiology; 2019 Dec; 293(3):554-564. PubMed ID: 31638489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower extremity deep venous thrombosis: evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism--preliminary experience.
    Li W; Salanitri J; Tutton S; Dunkle EE; Schneider JR; Caprini JA; Pierchala LN; Jacobs PM; Edelman RR
    Radiology; 2007 Mar; 242(3):873-81. PubMed ID: 17325072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferumoxytol as an intraprostatic MR contrast agent for lymph node mapping of the prostate: a feasibility study in non-human primates.
    Sankineni S; Smedley J; Bernardo M; Brown AM; Johnson L; Muller B; Griffiths GL; Kobayashi H; Rais-Bahrami S; Pinto PA; Wood BJ; Keele B; Choyke PL; Turkbey B
    Acta Radiol; 2016 Nov; 57(11):1396-1401. PubMed ID: 26013022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Ferumoxytol be Used as a Contrast Agent to Differentiate Between Acute and Chronic Inflammatory Kidney Disease?: Feasibility Study in a Rat Model.
    Budjan J; Neudecker S; Schock-Kusch D; Kraenzlin B; Schoenberg SO; Michaely HJ; Attenberger UI
    Invest Radiol; 2016 Feb; 51(2):100-5. PubMed ID: 26352750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage Imaging of Cerebral Aneurysms with Ferumoxytol: an Exploratory Study in an Animal Model and in Patients.
    Aoki T; Saito M; Koseki H; Tsuji K; Tsuji A; Murata K; Kasuya H; Morita A; Narumiya S; Nozaki K;
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2055-2064. PubMed ID: 28774792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI with ferumoxytol: A single center experience of safety across the age spectrum.
    Nguyen KL; Yoshida T; Han F; Ayad I; Reemtsen BL; Salusky IB; Satou GM; Hu P; Finn JP
    J Magn Reson Imaging; 2017 Mar; 45(3):804-812. PubMed ID: 27480885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Iron Assessment after Ferumoxytol-enhanced MRI in Children and Young Adults with Arteriovenous Malformations: A Case-Control Study.
    Iv M; Ng NN; Nair S; Zhang Y; Lavezo J; Cheshier SH; Holdsworth SJ; Moseley ME; Rosenberg J; Grant GA; Yeom KW
    Radiology; 2020 Nov; 297(2):438-446. PubMed ID: 32930651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of Off-Label Use of Ferumoxtyol as a Contrast Agent for MRI: A Systematic Review and Meta-Analysis of Adverse Events.
    Ahmad F; Treanor L; McGrath TA; Walker D; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2021 Mar; 53(3):840-858. PubMed ID: 33098154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental ferumoxytol artifacts in clinical brain MR imaging.
    Bowser BA; Campeau NG; Carr CM; Diehn FE; McDonald JS; Miller GM; Kaufmann TJ
    Neuroradiology; 2016 Nov; 58(11):1087-1091. PubMed ID: 27704163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.